Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2026-05-29 @ 9:59 AM
Study NCT ID:
NCT00942734
Status:
COMPLETED
Last Update Posted:
2025-05-01
First Post:
2009-07-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2008-0567
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None